Effectiveness, Tolerability, and Impact on Quality of Life of the 5% Lidocaine Patch in Diabetic Polyneuropathy
Authors:
- Richard L. BarbanoRBRichard L. Barbano
- David N. HerrmannDHDavid N. Herrmann
- Stephanie Hart-GouleauSHStephanie Hart-Gouleau
- Janet Pennella-VaughanJPJanet Pennella-Vaughan
- Peter A. LodewickPLPeter A. Lodewick
- Robert H. DworkinRDRobert H. Dworkin
- 1 June 2004
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 61 (6) , 914-918
Abstract
Research from JAMA Neurology — Effectiveness, Tolerability, and Impact on Quality of Life of the 5% Lidocaine Patch in Diabetic PolyneuropathyKeywords
This publication has 7 references indexed in Scilit:
- Epidemiology and Impact on Quality of Life of Postherpetic Neuralgia and Painful Diabetic NeuropathyThe Clinical Journal of Pain, 2002
- Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePain, 2001
- Topical Lidocaine Patch Relieves a Variety of Neuropathic Pain Conditions: An Open-Label StudyThe Clinical Journal of Pain, 2000
- Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment studyPain, 1999
- Is postherpetic neuralgia more than one disorder?Pain Forum, 1998
- The short-form McGill pain questionnairePain, 1987
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961